Several reports have shown that resveratrol has inhibitory effects on various types of cancer cell lines and preclinical animal models of various cancers, such as colon, breast and lymphoma, through its activity on diverse subcellular targets, including Sirt1 [15,16,17,18,19,20,21]. This evidence concerns the gene SIRT1 and cancer.